Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). (Q53344976)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). |
scientific article |
Statements
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). (English)
1 reference
Califf RM
1 reference
Zannad F
1 reference
Swedberg K
1 reference
O'Connor CM
1 reference
Gattis WA
1 reference
Uretsky BF
1 reference
Adams KF Jr
1 reference
McNulty SE
1 reference
Grossman SH
1 reference
McKenna WJ
1 reference
Gheorghiade M
1 reference
1 July 1999
1 reference
138
1 reference
1 Pt 1
1 reference
78-86
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference